Neuronal Differentiation Using Cerebrospinal Fluid Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for inducing neuronal differentiation from mesenchymal stem cells (MSCs) are limited in efficiency and specificity, particularly in generating terminally differentiated neurons, astrocytes, and oligodendrocytes, which are crucial for treating neurodegenerative disorders.

Innovation Solution

A method involving culturing MSCs in a first medium with growth factors to form neuralized MSCs, followed by proliferation and subsequent differentiation in cerebrospinal fluid (CSF) to achieve a population of terminally differentiated neurons, astrocytes, and oligodendrocytes, utilizing specific markers and growth factors like EGF and bFGF, and CSF to induce cell differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If MSCs are cultured with growth factors to induce neuronal differentiation, then neuronal cell types are generated, but the efficiency and specificity of generating terminally differentiated neurons, astrocytes, and oligodendrocytes is limited

Engineering Contradiction:
Improveefficiency of generating terminally differentiated neuronal cellsVSAvoidspecificity of generating specific neuronal cell types
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The differentiation process is divided into distinct sequential stages: first forming neuralized MSCs (NMSC) in a neural induction medium, then transitioning to cerebrospinal fluid (CSF) for terminal differentiation. This segmentation allows each stage to be optimized independently, improving both efficiency and specificity of generating terminally differentiated neuronal cells.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Cerebrospinal fluid (CSF) is used as an intermediary medium that contains endogenous growth factors and cytokines to drive terminal differentiation. The CSF acts as a natural mediator that guides NMSCs to differentiate into specific neuronal cell types (neurons, astrocytes, oligodendrocytes) with high specificity, resolving the contradiction between efficiency and precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If multiple growth factors are used to enhance neuronal differentiation, then differentiation efficiency improves, but the complexity of the culture system increases

Engineering Contradiction:
Improveneuronal differentiation efficiencyVSAvoidcomplexity of culture medium composition
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The cerebrospinal fluid (CSF) contains a natural mixture of growth factors, cytokines, and other bioactive molecules that self-organize to support terminal differentiation. This self-service approach eliminates the need for manual addition of multiple individual growth factors, reducing culture system complexity while maintaining high differentiation efficiency.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention changes the fundamental parameter of culture medium composition by using CSF instead of conventional defined media with multiple added growth factors. This parameter change simplifies the system while achieving superior differentiation outcomes, as CSF naturally contains the appropriate concentration and combination of differentiation-inducing factors.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If MSCs are differentiated into neuronal lineages, then neurotrophic effects are achieved, but the cells retain mesodermal differentiation potential which reduces purity

Engineering Contradiction:
Improveneurotrophic effect reliabilityVSAvoidcell lineage purity
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The method performs preliminary neuralization of MSCs to form NMSCs before terminal differentiation. This preliminary action commits the cells to the neural lineage early in the process, ensuring that subsequent differentiation in CSF produces pure neuronal lineages (neurons, astrocytes, oligodendrocytes) without retaining mesodermal potential, thus achieving both reliability and purity.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively generates statistically significant amounts of terminally differentiated neuronal cells with specific markers, losing mesodermal differentiation potential, and exhibits immunomodulatory properties and neurotrophic effects, improving clinical scores in animal models of neurodegenerative diseases.

Implementation Method 1

culturing the NMSC in a second culture media comprising cerebrospinal fluid (CSF) for a time sufficient for the NMSC to differentiate into a population of cells comprising terminally differentiated neurons, astrocytes and oligodendrocytes

Methodology Applied
Scientific EffectCell differentiation:

Implementation Method 2

culturing MSCs in a first culture medium comprising a growth factor selected to allow formation of neuralized MSCs (NMSC)

Methodology Applied
Scientific EffectGrowth factor signaling:

Data Source

PatentEP3354725B1Terminally differentiated neuronal lineages and uses thereof
Publication Date: 2019.12.04 HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD
  • EP3354725B1 patent drawingFigure 1A~1C
  • EP3354725B1 patent drawingFigure 2A~2D
  • EP3354725B1 patent drawingFigure 3~4B

AI summary

The present disclosure concerns a method of inducing transdifferentiation of mesenchymal stem cells (MSC), the method comprising (a) culturing MSC in a first culture medium comprising a growth factor selected for allowing formation of neuralized MSC (NMSC); (b) allowing the NMSC to proliferate for a sufficient time during which said culture medium is renewed at least once; and (c) culturing the NMSC of (b) in a second culture media comprising cerebrospinal fluid (CSF) for a time sufficient for the NMSC to differentiate into a population of cells comprising terminally differentiated neurons, astrocytes and oligodendrocytes. Also provided by the present invention is the use of MSC or NMSC for providing a composition comprising said population and to kits comprising MSC or NMSC and instructions for use of same.